Author(s): Gates C, Pinney RJ
Abstract Share this page
Abstract In recent years, new formulations of the original amphotericin B preparation (Fungizone) have been devised in order to overcome toxicity problems that frequently occur. These preparations represent an improved method of drug delivery, with an increased therapeutic index and a decrease in toxicity to mammalian cell membranes. The new formulations have different physico-chemical characteristics and differ in pharmacokinetic parameters. Their effects must be compared with conventional amphotericin B to ascertain potential roles in future antifungal therapy.
This article was published in J Clin Pharm Ther
and referenced in Journal of Nanomedicine & Nanotechnology